Matthew M. Walsh - Aug 5, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Financial Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Stock symbol
OGN
Transactions as of
Aug 5, 2023
Transactions value $
-$236,959
Form type
4
Date filed
8/8/2023, 06:07 PM
Previous filing
May 25, 2023
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +22.3K +54.41% 63.4K Aug 5, 2023 Direct F1
transaction OGN Common Stock Tax liability -$237K -11K -17.35% $21.53 52.4K Aug 5, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -22.3K -100% $0.00* 0 Aug 5, 2023 Common Stock 22.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2 On each of August 5, 2021, August 5, 2022 and August 5, 2023, one-third of the RSUs vested.